178 related articles for article (PubMed ID: 34953855)
1. The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase.
Heppler LN; Attarha S; Persaud R; Brown JI; Wang P; Petrova B; Tošić I; Burton FB; Flamand Y; Walker SR; Yeh JE; Zubarev RA; Gaetani M; Kanarek N; Page BDG; Frank DA
J Biol Chem; 2022 Feb; 298(2):101531. PubMed ID: 34953855
[TBL] [Abstract][Full Text] [Related]
2. The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer.
Khan MW; Saadalla A; Ewida AH; Al-Katranji K; Al-Saoudi G; Giaccone ZT; Gounari F; Zhang M; Frank DA; Khazaie K
Cancer Immunol Immunother; 2018 Jan; 67(1):13-23. PubMed ID: 28875329
[TBL] [Abstract][Full Text] [Related]
3. Altered dihydrofolate reductase in pyrimethamine-resistant Plasmodium falciparum.
Walter RD
Mol Biochem Parasitol; 1986 Apr; 19(1):61-6. PubMed ID: 3520313
[TBL] [Abstract][Full Text] [Related]
4. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
5. Dihydrofolate reductase from Eimeria tenella: rationalization of chemotherapeutic efficacy of pyrimethamine.
Wang CC; Stotish RL; Poe M
J Protozool; 1975 Nov; 22(4):564-8. PubMed ID: 1059772
[TBL] [Abstract][Full Text] [Related]
6. Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity.
Wu B; Fathi S; Mortley S; Mohiuddin M; Jang YC; Oyelere AK
Bioorg Med Chem; 2020 Mar; 28(6):115345. PubMed ID: 32061484
[TBL] [Abstract][Full Text] [Related]
7. High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate.
Zolli-Juran M; Cechetto JD; Hartlen R; Daigle DM; Brown ED
Bioorg Med Chem Lett; 2003 Aug; 13(15):2493-6. PubMed ID: 12852950
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel STAT3 DNA binding domain inhibitors.
Wu B; Payero B; Taylor S; Oyelere AK
Future Med Chem; 2021 Aug; 13(15):1253-1269. PubMed ID: 34180263
[No Abstract] [Full Text] [Related]
10. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance.
de Pécoulas PE; Tahar R; Ouatas T; Mazabraud A; Basco LK
Mol Biochem Parasitol; 1998 May; 92(2):265-73. PubMed ID: 9657331
[TBL] [Abstract][Full Text] [Related]
11. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.
Kim BH; Yin CH; Guo Q; Bach EA; Lee H; Sandoval C; Jayabose S; Ulaczyk-Lesanko A; Hall DG; Baeg GH
Mol Cancer Ther; 2008 Sep; 7(9):2672-80. PubMed ID: 18790749
[TBL] [Abstract][Full Text] [Related]
12. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.
Sirawaraporn W; Yuthavong Y
Mol Biochem Parasitol; 1984 Mar; 10(3):355-67. PubMed ID: 6727925
[TBL] [Abstract][Full Text] [Related]
13. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.
Takakura A; Nelson EA; Haque N; Humphreys BD; Zandi-Nejad K; Frank DA; Zhou J
Hum Mol Genet; 2011 Nov; 20(21):4143-54. PubMed ID: 21821671
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells.
Kulesza DW; Ramji K; Maleszewska M; Mieczkowski J; Dabrowski M; Chouaib S; Kaminska B
Lab Invest; 2019 Nov; 99(11):1607-1621. PubMed ID: 31278347
[TBL] [Abstract][Full Text] [Related]
16. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
[TBL] [Abstract][Full Text] [Related]
17. Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.
Bacon DJ; Tang D; Salas C; Roncal N; Lucas C; Gerena L; Tapia L; Llanos-Cuentas AA; Garcia C; Solari L; Kyle D; Magill AJ
PLoS One; 2009 Aug; 4(8):e6762. PubMed ID: 19707564
[TBL] [Abstract][Full Text] [Related]
18. Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.
Sandefur CI; Wooden JM; Quaye IK; Sirawaraporn W; Sibley CH
Mol Biochem Parasitol; 2007 Jul; 154(1):1-5. PubMed ID: 17451822
[TBL] [Abstract][Full Text] [Related]
19. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
20. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
